Gastroenterology

Can you diagnose this adolescent with an 11-day history of diffuse targetoid and bullous lesions on his extremities and trunk?

"The quest for a cure for colic continues," noted Jon Matthew Farber, MD.

Editor-in-chief Tina Tan, MD, FAAP, FIDSA, FPIDS, highlights the August 2024 issue of Contemporary Pediatrics.

Following the FDA's acceptance of the NDA, a PDUFA date of December 26, 2024 has been set for setmelanotide in patients as young as 2 years of age.

The USPSTF statement aligns with the 2015 recommendation on insufficient evidence for pregnancy iron deficiency screening or supplementation.

Digital tools like health apps, texts, and telemedicine show promise in managing childhood obesity, but require sustained engagement for long-term impact.

Wondering how to counsel parents on keeping their child’s immune system healthy through nutrition? Check out these clinical pearls from Colleen Sloan, PPA-C, RDN.

Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN, shares her thoughts on the July 2024 issue of Contemporary Pediatrics.

Get caught up with our journal! Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

Get caught up with our journal! Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

Wondering what’s the best way to talk to children about their weight? Colleen Sloan, PA-C, RDN, provides some clinical pearls you can incorporate into your practice.

The USPSTF is encouraging providers to promote behavioral interventions as the primary effective intervention for weight loss in children and adolescents.

Editor-in-chief Tina Tan, MD, FAAP, FIDSA, FPIDS, highlights the June 2024 issue of Contemporary Pediatrics.

A recent study suggests that high ultraprocessed food consumption in preschool children is linked to increased cardiometabolic risk factors.

Investigators found that higher baseline HbA1c was associated with greater T2D risk.

“We found no statistically significant effect of early iron supplementation on developmental scores at 24 and 36 months,” wrote the study investigators.

When breastfeeding is not an option, caregivers will turn to infant formulas to meet their child’s nutritional needs.

Across all age groups, obesity rates increased during the pandemic and decreased in the post-pandemic period (P < 0.01).

A poster session evaluated early evidence from the randomized controlled iREACH trial.

A recent nationally representative survey revealed what types of meals parents believe are healthy for their children, and how much food is the healthy amount.

The FDA has approved lutetium Lu 177 dotatate for pediatric patients with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors.

Treatment with intravenous iron therapy proves more efficacious than oral or no iron therapy in improving hemoglobin in pediatric patients admitted with IBD and IDA.

A discussion of outpatient management and treatment of eating disorders in youth patients, plus the importance of a multidisciplinary team throughout the process.

Latest guidelines, treatments, and when to refer to a specialist.

TNX-2900 was previously granted Orphan Drug designation by the federal agency in 2022 for the treatment of PWS.

Take this short quiz and test your knowledge of the American Academy of Pediatrics' clinical practice guideline to evaluate and treat children and adolescents with obesity.

Gluten-free meal plans can be a critical treatment option and necessity for those with celiac disease. But for children with no medical conditions or restrictions? A gluten-free diet should not be the mainstay diet.

The approval makes dupilumab the first and only treatment specifically indicated for eosinophilic esophagitis (EoE) patients aged 1 to 11 years that weigh at least 33 lbs (15 kg).

Though the association of BMI gain and 100% fruit juice in children was “small,” authors concluded their findings support public health guidance to limit consumption of the beverage to prevent overweight and obesity.

Compared to placebo, linaclotide demonstrated a statistically significant and clinically meaningful improvement in spontaneous bowel movement(s) (SBM) frequency rate, and was subsequently approved by the FDA in June 2023.